| 000 | 01491 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516013737.0 | ||
| 264 | 0 | _c20110516 | |
| 008 | 201105s 0 0 eng d | ||
| 022 | _a1463-1326 | ||
| 024 | 7 |
_a10.1111/j.1463-1326.2010.01322.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMorrow, L | |
| 245 | 0 | 0 |
_aCo-administration of liraglutide with insulin detemir demonstrates additive pharmacodynamic effects with no pharmacokinetic interaction. _h[electronic resource] |
| 260 |
_bDiabetes, obesity & metabolism _cJan 2011 |
||
| 300 |
_a75-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucagon-Like Peptide 1 _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aInsulin _xadministration & dosage |
| 650 | 0 | 4 | _aInsulin Detemir |
| 650 | 0 | 4 | _aInsulin, Long-Acting |
| 650 | 0 | 4 | _aLiraglutide |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHompesch, M | |
| 700 | 1 | _aGuthrie, H | |
| 700 | 1 | _aChang, D | |
| 700 | 1 | _aChatterjee, D J | |
| 773 | 0 |
_tDiabetes, obesity & metabolism _gvol. 13 _gno. 1 _gp. 75-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1463-1326.2010.01322.x _zAvailable from publisher's website |
| 999 |
_c20407180 _d20407180 |
||